# Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

> **NCT01823770** · PHASE4 · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 130 (actual)

## Conditions studied

- Restless Legs Syndrome (RLS)

## Interventions

- **DRUG:** Rotigotine
- **DRUG:** Placebo patchs

## Key facts

- **NCT ID:** NCT01823770
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-26
- **Primary completion:** 2016-07-04
- **Final completion:** 2017-06-23
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2018-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01823770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01823770, "Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01823770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*